News
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...
Tonight’s Hot Topic Tuesday revisits injectable weight-loss drugs and the new discoveries coming out about the medications.
Wegovy launched here is to support Singapore’s efforts in improving population health: Novo Nordisk Read more at straitstimes.com. Read more at straitstimes.com.
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes ...
More than 40% of Americans are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic isn ...
New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...
The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...
4d
News-Medical.Net on MSNCan one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonistsLandmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
1d
Best Life on MSNDoctors Sound Alarm on Weight-Loss Drugs and Death RiskRELATED: Doctors Warn That Drugs Like Ozempic Are Making You “Skinny Fat.” Any time a person suddenly loses weight, they are ...
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...
The Telegraph and Argus on MSN11d
Weight loss jabs linked to lower dementia and stroke riskWeight loss jabs may offer a protective effect against dementia and stroke, according to a new study. People with type 2 ...
The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results